What is the Laurus Labs Ltd share price today?

The share price of NSE:LAURUSLABS-EQ on 01 Oct 2026 (as of 15:04:06 IST) is ₹1974.3.

What is the NSE:LAURUSLABS-EQ 52 week high low price?

Over the past 52 weeks (as of 01 Oct 2026), the NSE:LAURUSLABS-EQ 52 week high low range shows a high of ₹2055.3 and a low of ₹843.

What is the Laurus Labs Ltd market cap?

As on 01 Oct 2026, Laurus Labs Ltd market cap is ₹1070680000000.

What is the shareholding pattern of Laurus Labs Ltd Stock?

The shareholding pattern of Laurus Labs Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 27.47% Foreign Institutional Investors (FII): 28% Domestic Institutional Investors (DII): 3.58% Mutual Funds: 10.15% Retail & Others: 30.8% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Laurus Labs Ltd?

The Price-to-Earnings (PE) ratio of Laurus Labs Ltd is 97.925, and the Price-to-Book (PB) ratio is 10.1506, as on 01 Oct 2026.

Laurus Labs Share Price

2323.00-25.00 (-1.06%)

+143.59% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Login to analyze with FIA

1 Day

-1.06%

1 Week

+3.52%

1 Month

+17.09%

3 Month

+26.59%

6 Month

+92.54%

YTD

+109.66%

1 Year

+143.59%

5 Year

+372.78%

10 Year

NA

Max

+2270.89%

1D

1W

1M

3M

6M

YTD

1Y

5Y

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

2252.40

2206.10

1933.50

1769.40

1206.00

917.95

High

2354.90

2441.90

About

Laurus Labs is engaged in offering a broad and integrated portfolio of Active Pharmaceuticals Ingredients (API) including intermediates, Generic Finished Dosage Forms (FDF) and Contract Research services to cater to Read more

Pharmaceuticals & Drugs

Midcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

SUNPHARMANSE

DIVISLABNSE

TORNTPHARMNSE

LAURUSLABSNSE

ZYDUSLIFENSE

DRREDDYNSE

CIPLANSE

MANKINDNSE

AUROPHARMANSE

LUPINNSE

LTP

1W Low

1W High

Market cap (₹)

1769.9+8.9 (0.51%)

1722

1855

4,24,202Cr

10064+400 (4.14%)

9621.50

10064

2,64,141Cr

4650+70 (1.53%)

4532

4675

1,74,402Cr

2323+79 (3.52%)

2206.10

2441.90

1,26,811Cr

1240.6+56.2 (4.75%)

1182

1254.20

1,23,685Cr

1368.3+23.3 (1.73%)

1336.70

1368.30

1,11,868Cr

1396.9+38.9 (2.86%)

1357

1396.90

1,11,650Cr

2475+5.7 (0.23%)

2457.90

2528

1,02,196Cr

1694.5+34.6 (2.08%)

1647.20

1697.40

96,951Cr

2015.9+26 (1.31%)

1974

2033.80

91,301Cr

Laurus Labs Share Price

2323.00-25.00 (-1.06%)

+143.59% past 1 Year

Financial overview

Compounded Sales Growth

10 years14%

5 years7%

3 years4%

Last year23%

Compounded Profit Growth

10 years21%

5 years-2%

3 years4%

Last year151%

Stock Price CAGR

10 years-

5 years36%

3 years85%

1 year138%

Return on Equity

10 years18%

5 years16%

3 years10%

Last year18%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
14%	7%	4%	23%
21%	-2%	4%	151%
-	36%	85%	138%
18%	16%	10%	18%

Peer Comparison

Symbol

SUNPHARMA

DIVISLAB

TORNTPHARM

LAURUSLABS

ZYDUSLIFE

DRREDDY

CIPLA

MANKIND

AUROPHARMA

LUPIN

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
1,769.9	₹424202 Cr	38.68	8.29	58.23	₹11479 Cr
10,064	₹264141 Cr	90.3	34.04	128.41	₹2568 Cr
4,650	₹174402 Cr	82.11	14.04	106.21	₹2163 Cr
2,323	₹126811 Cr	94.64	8.17	33.94	₹889 Cr
1,240.6	₹123685 Cr	27.41	9.42	62.53	₹5040 Cr
1,368.3	₹111868 Cr	39.95	11.08	59.2	₹4196 Cr
1,396.9	₹111650 Cr	38.54	10.86	52.6	₹3879 Cr
2,475	₹102196 Cr	45.57	17.23	76.26	₹1913 Cr
1,694.5	₹96951 Cr	26.11	17.95	96.84	₹3505 Cr
2,015.9	₹91301 Cr	16.51	30.95	154.35	₹5333 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

%

Name

Net Revenue

Other Income

Total Revenue

Total Expenditure

Operating Profit

Interest Expense

PBT

Net Profit

Sep 2026	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021	Mar 2021	Dec 2020	Sep 2020	Jun 2020	Mar 2020	Dec 2019	Sep 2019	Jun 2019	Mar 2019	Dec 2018	Sep 2018	Jun 2018	Mar 2018	Dec 2017	Sep 2017	Jun 2017	Mar 2017	Dec 2016	Sep 2016	Jun 2016
₹2206 Cr	₹2026 Cr	₹1812 Cr	₹1778 Cr	₹1653 Cr	₹1570 Cr	₹1720 Cr	₹1415 Cr	₹1224 Cr	₹1195 Cr	₹1440 Cr	₹1195 Cr	₹1224 Cr	₹1182 Cr	₹1381 Cr	₹1545 Cr	₹1576 Cr	₹1539 Cr	₹1425 Cr	₹1029 Cr	₹1203 Cr	₹1279 Cr	₹1412 Cr	₹1288 Cr	₹1139 Cr	₹974 Cr	₹839 Cr	₹730 Cr	₹712 Cr	₹551 Cr	₹635 Cr	₹529 Cr	₹588 Cr	₹539 Cr	₹560 Cr	₹479 Cr	₹539 Cr	₹491 Cr	₹480 Cr	₹510 Cr	₹525 Cr	₹416 Cr
₹13 Cr	₹9 Cr	₹12 Cr	₹6 Cr	₹27 Cr	₹10 Cr	₹59 Cr	₹9 Cr	₹5 Cr	₹3 Cr	₹19 Cr	₹2 Cr	₹2 Cr	₹4 Cr	₹2 Cr	₹1 Cr	₹1 Cr	₹2 Cr	₹1 Cr	₹5 Cr	₹3 Cr	₹6 Cr	₹5 Cr	₹7 Cr	₹5 Cr	₹7 Cr	₹2 Cr	₹2 Cr	₹1 Cr	₹5 Cr	₹2 Cr	₹1 Cr	₹11 Cr	₹3 Cr	₹5 Cr	₹10 Cr	₹7 Cr	₹8 Cr	₹10 Cr	₹13 Cr	₹8 Cr	₹2 Cr
₹2219 Cr	₹2035 Cr	₹1823 Cr	₹1784 Cr	₹1680 Cr	₹1580 Cr	₹1779 Cr	₹1424 Cr	₹1228 Cr	₹1197 Cr	₹1458 Cr	₹1197 Cr	₹1226 Cr	₹1185 Cr	₹1383 Cr	₹1546 Cr	₹1577 Cr	₹1541 Cr	₹1426 Cr	₹1034 Cr	₹1206 Cr	₹1284 Cr	₹1416 Cr	₹1295 Cr	₹1144 Cr	₹981 Cr	₹841 Cr	₹732 Cr	₹714 Cr	₹555 Cr	₹637 Cr	₹531 Cr	₹599 Cr	₹542 Cr	₹565 Cr	₹489 Cr	₹545 Cr	₹499 Cr	₹490 Cr	₹523 Cr	₹533 Cr	₹419 Cr
₹1583 Cr	₹1512 Cr	₹1422 Cr	₹1419 Cr	₹1371 Cr	₹1304 Cr	₹1410 Cr	₹1236 Cr	₹1153 Cr	₹1130 Cr	₹1300 Cr	₹1112 Cr	₹1130 Cr	₹1106 Cr	₹1182 Cr	₹1226 Cr	₹1209 Cr	₹1156 Cr	₹1094 Cr	₹807 Cr	₹922 Cr	₹942 Cr	₹993 Cr	₹914 Cr	₹816 Cr	₹745 Cr	₹693 Cr	₹629 Cr	₹622 Cr	₹513 Cr	₹567 Cr	₹484 Cr	₹552 Cr	₹497 Cr	₹478 Cr	₹423 Cr	₹456 Cr	₹424 Cr	₹393 Cr	₹438 Cr	₹443 Cr	₹356 Cr
₹763 Cr	₹647 Cr	₹524 Cr	₹486 Cr	₹430 Cr	₹393 Cr	₹479 Cr	₹295 Cr	₹183 Cr	₹174 Cr	₹260 Cr	₹184 Cr	₹190 Cr	₹170 Cr	₹287 Cr	₹405 Cr	₹450 Cr	₹456 Cr	₹398 Cr	₹291 Cr	₹348 Cr	₹401 Cr	₹477 Cr	₹433 Cr	₹379 Cr	₹285 Cr	₹193 Cr	₹150 Cr	₹139 Cr	₹88 Cr	₹114 Cr	₹89 Cr	₹86 Cr	₹83 Cr	₹122 Cr	₹97 Cr	₹119 Cr	₹104 Cr	₹125 Cr	₹112 Cr	₹116 Cr	₹87 Cr
₹44 Cr	₹42 Cr	₹40 Cr	₹39 Cr	₹40 Cr	₹52 Cr	₹56 Cr	₹58 Cr	₹53 Cr	₹49 Cr	₹51 Cr	₹51 Cr	₹42 Cr	₹39 Cr	₹53 Cr	₹43 Cr	₹40 Cr	₹29 Cr	₹31 Cr	₹23 Cr	₹22 Cr	₹27 Cr	₹22 Cr	₹17 Cr	₹14 Cr	₹15 Cr	₹21 Cr	₹21 Cr	₹26 Cr	₹23 Cr	₹18 Cr	₹24 Cr	₹25 Cr	₹22 Cr	₹23 Cr	₹18 Cr	₹20 Cr	₹19 Cr	₹16 Cr	₹31 Cr	₹25 Cr	₹28 Cr
₹592 Cr	₹481 Cr	₹361 Cr	₹327 Cr	₹270 Cr	₹224 Cr	₹312 Cr	₹131 Cr	₹23 Cr	₹18 Cr	₹107 Cr	₹35 Cr	₹54 Cr	₹41 Cr	₹147 Cr	₹278 Cr	₹328 Cr	₹356 Cr	₹302 Cr	₹204 Cr	₹263 Cr	₹316 Cr	₹401 Cr	₹364 Cr	₹314 Cr	₹221 Cr	₹127 Cr	₹82 Cr	₹66 Cr	₹19 Cr	₹53 Cr	₹23 Cr	₹22 Cr	₹23 Cr	₹64 Cr	₹49 Cr	₹70 Cr	₹55 Cr	₹81 Cr	₹54 Cr	₹66 Cr	₹35 Cr
₹437 Cr	₹362 Cr	₹282 Cr	₹253 Cr	₹194 Cr	₹161 Cr	₹234 Cr	₹91 Cr	₹18 Cr	₹12 Cr	₹75 Cr	₹25 Cr	₹39 Cr	₹28 Cr	₹107 Cr	₹203 Cr	₹234 Cr	₹253 Cr	₹232 Cr	₹155 Cr	₹204 Cr	₹242 Cr	₹297 Cr	₹273 Cr	₹242 Cr	₹172 Cr	₹110 Cr	₹73 Cr	₹57 Cr	₹15 Cr	₹43 Cr	₹18 Cr	₹16 Cr	₹17 Cr	₹45 Cr	₹35 Cr	₹49 Cr	₹39 Cr	₹71 Cr	₹45 Cr	₹49 Cr	₹27 Cr

Balance Sheet

Consolidated

Standalone

₹

%

Name

Equity And Liabilities

Share Capital

Share Warrants & Outstandings

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Minority Interest

Secured Loans

Unsecured Loans

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Long Term Provisions

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Capital Work in Progress

Non Current Investments

Long Term Investment

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Miscellaneous Expenses not written off

Total Assets

Book Value

Adjusted Book Value

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014
—	—	—	—	—	—	—	—	—	—	—	—	—
₹108 Cr	₹108 Cr	₹108 Cr	₹108 Cr	₹107 Cr	₹107 Cr	₹107 Cr	₹106 Cr	₹106 Cr	₹106 Cr	₹82 Cr	₹82 Cr	₹78 Cr
₹25 Cr	₹26 Cr	₹21 Cr	₹12 Cr	₹9 Cr	₹5 Cr	₹5 Cr	₹5 Cr	₹6 Cr	₹6 Cr	₹3 Cr	₹3 Cr	₹3 Cr
₹5167 Cr	₹4339 Cr	₹3982 Cr	₹3918 Cr	₹3235 Cr	₹2485 Cr	₹1658 Cr	₹1447 Cr	₹1371 Cr	₹1219 Cr	₹771 Cr	₹637 Cr	₹277 Cr
₹5167 Cr	₹4339 Cr	₹3982 Cr	₹3918 Cr	₹3235 Cr	₹2485 Cr	₹1658 Cr	₹1447 Cr	₹1371 Cr	₹1219 Cr	₹771 Cr	₹637 Cr	₹277 Cr
₹5300 Cr	₹4473 Cr	₹4111 Cr	₹4038 Cr	₹3351 Cr	₹2598 Cr	₹1770 Cr	₹1558 Cr	₹1483 Cr	₹1330 Cr	₹857 Cr	₹722 Cr	₹358 Cr
₹131 Cr	₹130 Cr	₹5 Cr	₹11 Cr	₹8 Cr	₹3 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹611 Cr	₹646 Cr	₹798 Cr	₹761 Cr	₹596 Cr	₹429 Cr	₹165 Cr	₹259 Cr	₹142 Cr	₹125 Cr	₹354 Cr	₹304 Cr	₹188 Cr
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹106 Cr	₹0	₹0
₹29 Cr	₹32 Cr	₹57 Cr	₹82 Cr	₹69 Cr	₹19 Cr	-₹74 Cr	-₹53 Cr	-₹53 Cr	-₹70 Cr	-₹55 Cr	₹10 Cr	₹12 Cr
₹672 Cr	₹410 Cr	₹210 Cr	₹254 Cr	₹190 Cr	₹181 Cr	₹77 Cr	₹60 Cr	₹65 Cr	₹63 Cr	₹16 Cr	₹45 Cr	₹0
₹132 Cr	₹106 Cr	₹93 Cr	₹81 Cr	₹73 Cr	₹63 Cr	₹46 Cr	₹30 Cr	₹21 Cr	₹15 Cr	₹7 Cr	₹5 Cr	₹4 Cr
₹1444 Cr	₹1193 Cr	₹1159 Cr	₹1179 Cr	₹928 Cr	₹693 Cr	₹214 Cr	₹295 Cr	₹174 Cr	₹132 Cr	₹428 Cr	₹364 Cr	₹204 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—
₹1252 Cr	₹958 Cr	₹1051 Cr	₹711 Cr	₹876 Cr	₹1179 Cr	₹616 Cr	₹488 Cr	₹312 Cr	₹263 Cr	₹248 Cr	₹231 Cr	₹227 Cr
₹799 Cr	₹780 Cr	₹611 Cr	₹641 Cr	₹840 Cr	₹367 Cr	₹261 Cr	₹244 Cr	₹231 Cr	₹199 Cr	₹141 Cr	₹133 Cr	₹164 Cr
₹1493 Cr	₹1715 Cr	₹1389 Cr	₹996 Cr	₹911 Cr	₹886 Cr	₹791 Cr	₹684 Cr	₹759 Cr	₹644 Cr	₹481 Cr	₹432 Cr	₹312 Cr
₹92 Cr	₹87 Cr	₹61 Cr	₹85 Cr	₹54 Cr	₹25 Cr	₹25 Cr	₹7 Cr	₹5 Cr	₹14 Cr	₹14 Cr	₹7 Cr	₹7 Cr
₹3635 Cr	₹3540 Cr	₹3112 Cr	₹2432 Cr	₹2681 Cr	₹2457 Cr	₹1692 Cr	₹1424 Cr	₹1307 Cr	₹1121 Cr	₹884 Cr	₹802 Cr	₹711 Cr
₹10511 Cr	₹9336 Cr	₹8387 Cr	₹7660 Cr	₹6968 Cr	₹5751 Cr	₹3676 Cr	₹3278 Cr	₹2964 Cr	₹2584 Cr	₹2169 Cr	₹1888 Cr	₹1273 Cr
₹421 Cr	₹426 Cr	₹154 Cr	₹152 Cr	₹119 Cr	₹122 Cr	₹104 Cr	₹103 Cr	₹92 Cr	₹48 Cr	₹56 Cr	₹185 Cr	₹169 Cr
₹2397 Cr	₹2693 Cr	₹2507 Cr	₹1972 Cr	₹1732 Cr	₹1453 Cr	₹1057 Cr	₹1036 Cr	₹980 Cr	₹842 Cr	₹1028 Cr	₹821 Cr	₹543 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—
₹6970 Cr	₹6284 Cr	₹5652 Cr	₹4795 Cr	₹3750 Cr	₹3028 Cr	₹2388 Cr	₹2105 Cr	₹1794 Cr	₹1419 Cr	₹1106 Cr	₹986 Cr	₹623 Cr
₹2600 Cr	₹2161 Cr	₹1762 Cr	₹1386 Cr	₹1098 Cr	₹857 Cr	₹661 Cr	₹476 Cr	₹313 Cr	₹189 Cr	₹85 Cr	₹185 Cr	₹124 Cr
₹4371 Cr	₹4123 Cr	₹3890 Cr	₹3409 Cr	₹2652 Cr	₹2171 Cr	₹1726 Cr	₹1629 Cr	₹1481 Cr	₹1230 Cr	₹1021 Cr	₹801 Cr	₹499 Cr
₹773 Cr	₹458 Cr	₹423 Cr	₹551 Cr	₹813 Cr	₹362 Cr	₹67 Cr	₹110 Cr	₹163 Cr	₹143 Cr	₹70 Cr	₹110 Cr	₹116 Cr
₹309 Cr	₹233 Cr	₹124 Cr	₹50 Cr	₹31 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹7 Cr	₹7 Cr	₹0
₹309 Cr	₹233 Cr	₹124 Cr	₹50 Cr	₹31 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹7 Cr	₹7 Cr	₹0
₹201 Cr	₹163 Cr	₹84 Cr	₹161 Cr	₹84 Cr	₹109 Cr	₹41 Cr	₹26 Cr	₹29 Cr	₹26 Cr	₹29 Cr	₹94 Cr	₹69 Cr
₹28 Cr	₹25 Cr	₹32 Cr	₹29 Cr	₹43 Cr	₹31 Cr	₹27 Cr	₹47 Cr	₹39 Cr	₹41 Cr	₹39 Cr	₹12 Cr	₹13 Cr
₹5682 Cr	₹5003 Cr	₹4552 Cr	₹4199 Cr	₹3623 Cr	₹2676 Cr	₹1864 Cr	₹1815 Cr	₹1716 Cr	₹1444 Cr	₹1166 Cr	₹1024 Cr	₹697 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—
₹2342 Cr	₹1937 Cr	₹1845 Cr	₹1685 Cr	₹1760 Cr	₹1575 Cr	₹905 Cr	₹682 Cr	₹585 Cr	₹509 Cr	₹487 Cr	₹475 Cr	₹328 Cr
₹2155 Cr	₹2007 Cr	₹1663 Cr	₹1580 Cr	₹1354 Cr	₹1306 Cr	₹791 Cr	₹710 Cr	₹571 Cr	₹568 Cr	₹445 Cr	₹285 Cr	₹195 Cr
₹114 Cr	₹144 Cr	₹142 Cr	₹48 Cr	₹76 Cr	₹48 Cr	₹2 Cr	₹3 Cr	₹3 Cr	₹4 Cr	₹29 Cr	₹59 Cr	₹23 Cr
₹34 Cr	₹37 Cr	₹38 Cr	₹39 Cr	₹20 Cr	₹57 Cr	₹52 Cr	₹33 Cr	₹31 Cr	₹34 Cr	₹18 Cr	₹20 Cr	₹9 Cr
₹184 Cr	₹207 Cr	₹147 Cr	₹109 Cr	₹134 Cr	₹88 Cr	₹62 Cr	₹35 Cr	₹59 Cr	₹25 Cr	₹24 Cr	₹23 Cr	₹20 Cr
₹4829 Cr	₹4332 Cr	₹3835 Cr	₹3462 Cr	₹3345 Cr	₹3075 Cr	₹1812 Cr	₹1463 Cr	₹1248 Cr	₹1140 Cr	₹1003 Cr	₹862 Cr	₹575 Cr
₹1194 Cr	₹793 Cr	₹723 Cr	₹1029 Cr	₹664 Cr	₹618 Cr	₹120 Cr	₹39 Cr	-₹59 Cr	₹19 Cr	₹119 Cr	₹60 Cr	-₹136 Cr
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹2 Cr	₹2 Cr
₹10511 Cr	₹9336 Cr	₹8387 Cr	₹7660 Cr	₹6968 Cr	₹5751 Cr	₹3676 Cr	₹3278 Cr	₹2964 Cr	₹2584 Cr	₹2169 Cr	₹1888 Cr	₹1273 Cr
₹98	₹82	₹76	₹75	₹62	₹48	₹165	₹146	₹139	₹125	₹499	₹420	₹189
₹98	₹82	₹76	₹75	₹62	₹48	₹33	₹29	₹28	₹25	₹25	₹21	₹9

Cash Flow

Consolidated

Standalone

₹

%

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Effect of Foreign Exchange Fluctuations

Closing Cash & Cash Equivalent

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014
₹1182 Cr	₹484 Cr	₹236 Cr	₹1109 Cr	₹1084 Cr	₹1301 Cr	₹294 Cr	₹120 Cr	₹237 Cr	₹235 Cr	₹169 Cr	₹67 Cr	₹121 Cr
₹710 Cr	₹630 Cr	₹563 Cr	₹486 Cr	₹351 Cr	₹254 Cr	₹293 Cr	₹248 Cr	₹216 Cr	₹199 Cr	₹201 Cr	₹136 Cr	₹83 Cr
₹25 Cr	-₹375 Cr	-₹29 Cr	-₹315 Cr	-₹342 Cr	-₹594 Cr	-₹200 Cr	-₹44 Cr	-₹49 Cr	-₹52 Cr	-₹154 Cr	-₹251 Cr	-₹59 Cr
₹1917 Cr	₹739 Cr	₹770 Cr	₹1279 Cr	₹1093 Cr	₹962 Cr	₹387 Cr	₹323 Cr	₹404 Cr	₹382 Cr	₹215 Cr	-₹48 Cr	₹145 Cr
₹1624 Cr	₹602 Cr	₹666 Cr	₹994 Cr	₹911 Cr	₹733 Cr	₹347 Cr	₹298 Cr	₹342 Cr	₹332 Cr	₹182 Cr	-₹65 Cr	₹121 Cr
-₹1089 Cr	-₹682 Cr	-₹822 Cr	-₹996 Cr	-₹914 Cr	-₹941 Cr	-₹221 Cr	-₹253 Cr	-₹384 Cr	-₹289 Cr	-₹312 Cr	-₹397 Cr	-₹312 Cr
-₹525 Cr	₹39 Cr	₹250 Cr	-₹27 Cr	₹30 Cr	₹255 Cr	-₹128 Cr	-₹45 Cr	₹42 Cr	-₹54 Cr	₹103 Cr	₹486 Cr	₹203 Cr
₹10 Cr	-₹41 Cr	₹93 Cr	-₹29 Cr	₹27 Cr	₹47 Cr	-₹1 Cr	₹2 L	₹59 L	-₹10 Cr	-₹27 Cr	₹24 Cr	₹12 Cr
₹100 Cr	₹139 Cr	₹46 Cr	₹75 Cr	₹48 Cr	₹2 Cr	₹3 Cr	₹3 Cr	₹2 Cr	₹13 Cr	₹40 Cr	₹15 Cr	₹3 Cr
₹3 Cr	₹1 Cr	₹17 L	-₹88 L	-₹13 L	₹6 L	₹9 L	-₹5 L	-₹40,000	-₹9 L	₹19 L	₹0	₹0
₹113 Cr	₹100 Cr	₹139 Cr	₹46 Cr	₹75 Cr	₹48 Cr	₹2 Cr	₹3 Cr	₹3 Cr	₹2 Cr	₹13 Cr	₹40 Cr	₹15 Cr

Fundamental Ratios

Consolidated

Standalone

No results found

Laurus Labs Share Price

2323.00-25.00 (-1.06%)

+143.59% past 1 Year

02 Jan 25+9D

Bid/Ask

Price

Greeks

Stradle

Custom

CALLS

Qty/ots

PUTS

Sign in to View

Open a free Demat account in minutes to start investing and screening .

Login Sign Up

Laurus Labs Share Price

2323.00-25.00 (-1.06%)

+143.59% past 1 Year

Technical meters

Oscillators

Strong SellSellNeutralBuyStrong Buy

Bullish signals: 5

Bearish signals: 2 out of 9 oscillators

RSI

68.92Buy

STOCH %K

76.61Neutral

MACD Level(12,26)

89.19Buy

Ultimate Oscillator

74.64Buy

Aroon Oscillator

94.00Buy

BOP

-0.26Sell

CCI

149.36Sell

Williams %R

-23.39Neutral

Momentum

263.60Buy

Moving averages

Strong SellSellNeutralBuyStrong Buy

Bullish signals: 9

Bearish signals: 0 out of 9 moving averages

EMA 9

2228.16Buy

SMA 9

2186.20Buy

EMA 21

2131.51Buy

SMA 21

2100.48Buy

EMA 50

2006.84Buy

SMA 50

2002.75Buy

EMA 200

1564.16Buy

SMA 200

1461.42Buy

WMA 20

2156.18Buy

Pivot

Classic

Resistance 5

2758.57

Resistance 4

2663.67

Resistance 3

2568.77

Resistance 2

2473.87

Resistance 1

2410.93

Pivot

2378.97

Support 1

2316.03

Support 2

2284.07

Support 3

2189.17

Support 4

2094.27

Support 5

1999.37

High & lows

1 Day

1 Week

1 Month

3 Months

6 Months

Year to Date

1 Year

3 Years

5 Years

10 Years

All Time

Low

2252.40

2206.10

1933.50

1769.40

1206.00

917.95

360.85

278.85

59.00

High

2354.90

2441.90

Returns

-25.00

+79.00

+339.00

+488.00

+1116.50

+1215.00

+1369.35

+1960.70

+1831.65

—

+2225.02

Beta

—

Std. deviation %

—

Sign in to view

Open a free Demat account in minutes to start investing and screening .

Laurus Labs Share Price

2323.00-25.00 (-1.06%)

+143.59% past 1 Year

Shareholding summary

Promoters

27.47%

FII

30.84%

DII

3.6%

MF

8.26%

Others

29.83%

Promoters

FII

DII

MF

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Sep 2026	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025
27.47%	27.47%	27.49%	27.49%	27.59%	27.59%
30.84%	28.00%	25.82%	26.52%	26.17%	25.70%
3.60%	3.58%	2.74%	2.93%	3.19%	4.16%
8.26%	10.15%	11.22%	9.49%	8.53%	7.78%
29.83%	30.80%	32.73%	33.57%	34.52%	34.77%

Bulk & block deals

Name

Integrated Core Strategies (Asia) Pte. Ltd.

Bnp Paribas Financial Markets

Integrated Core Strategies (Asia) Pte. Ltd.

Bnp Paribas Financial Markets

Societe Generale

Graviton Research Capital Llp

Cybage Software Private Limited

Arun Vijay Nathani

Ishares Core Msci Emerging Markets Etf

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
31 Aug 2026	Purchase	33.03 L	₹1,922.69	1.72 K	Bulk	0.000318	NSE
31 Aug 2026	Purchase	2.86 Cr	₹1,860.35	15.40 K	Bulk	0.00285	NSE
31 Aug 2026	Sell	982.74 Cr	₹1,914.04	51.34 L	Bulk	0.950258	NSE
31 Aug 2026	Sell	1,200.67 Cr	₹1,914.28	62.72 L	Bulk	1.160843	NSE
31 Aug 2026	Sell	535.06 Cr	₹1,903.84	28.10 L	Bulk	0.520151	NSE
27 Jan 2025	Purchase	198.01 Cr	₹536.50	36.91 L	Bulk	0.683646	NSE
27 Jan 2025	Sell	197.82 Cr	₹536.23	36.89 L	Bulk	0.683331	NSE
14 Mar 2023	Sell	19.39 Cr	₹305	6.36 L	Block	0.11769	NSE
14 Mar 2023	Purchase	19.39 Cr	₹305	6.36 L	Block	0.11769	NSE
14 Nov 2022	Purchase	24.11 Cr	₹455.40	5.29 L	Block	0.097969	NSE

Insider trading & SAST

Client name

Mirae Asset Mutual Fund

Chunduru Venkata Lakshmana Rao

Satyanarayana Chava

Nagarani Chava

Satyanarayana Chava

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
05 Mar 2026	Other	Acquisition	0.02	4.03	—	1.11 L	18 Feb 2026	Market	2,17,37,464	SAST	29(2)	—
01 Aug 2025	Other	Acquisition	1.87	2.03	—	8.59 L	29 Jul 2025	Market	1,09,58,934	SAST	29(2)	—
01 Feb 2025	Other	Disposal	0.06	—	—	3 L	30 Jan 2025	Market	2,934	SAST	29(2)	—
24 Dec 2024	Promoter	Pledge	—	—	—	8 L	12 Mar 2021	Release	17,00,000	SAST	Reg31	—
24 Dec 2024	Promoter	Pledge	—	—	—	57.50 L	09 Mar 2021	Release	57,50,000	SAST	Reg31	—
24 Dec 2024	Promoter	Pledge	—	—	—	65.75 L	09 Mar 2021	Release	1,15,00,000	SAST	Reg31	—
24 Dec 2024	Promoter	Pledge	—	—	—	57.50 L	12 Mar 2021	Release	0	SAST	Reg31	—
24 Dec 2024	Promoter	Pledge	—	—	—	37.50 L	09 Mar 2021	Release	0	SAST	Reg31	—
24 Dec 2024	Promoter	Pledge	—	—	—	11 L	08 Dec 2020	Creation	2,02,75,000	SAST	Reg31	—
24 Dec 2024	Promoter	Pledge	—	—	—	17.50 L	07 Dec 2020	Release	2,02,75,000	SAST	Reg31	—

Laurus Labs Share Price

2323.00-25.00 (-1.06%)

+143.59% past 1 Year

Laurus Labs is engaged in offering a broad and integrated portfolio of Active Pharmaceuticals Ingredients (API) including intermediates, Generic Finished Dosage Forms (FDF) and Contract Research services to cater to

Corporate Actions

Date

Type

Details

2026-11-06

Dividend

1.0

2026-05-08

Dividend

1.2

2025-10-31

Dividend

0.8

2025-05-09

Dividend

0.8

2024-11-06

Dividend

0.4

2024-05-08

Dividend

0.4

2023-11-02

Dividend

0.4

2023-05-10

Dividend

1.2

2022-11-03

Dividend

0.8

2022-05-10

Dividend

1.2

2021-11-17

Dividend

0.8

2021-05-11

Dividend

0.8

2021-02-08

Dividend

0.4

2020-11-10

Dividend

0.8

2020-09-29

Split

10:2

2020-07-01

Dividend

1.0

2020-03-23

Dividend

1.5

2019-07-03

Dividend

1.5

2018-06-28

Dividend

1.5

2017-07-06

Dividend

1.5

Company details

Registered office

Laurus Enclave, Plot Office 01 Edulapaka Bonangi Village, Parawada Mandal, Anakapalli Vishakhapatnam Andhra Pradesh PIN: 531021 Tel No: 0891 6821101 / 1102 Fax No: 0891 6821103 Email: [email protected] Internet: www.lauruslabs.com

Registrars

Karvy Selenium Tower B, Plot 31-32Gachibowli,Financial District, NanakramgudaHyderabad – 500032Tel. No. 040 67161500Fax. No. 040 23001153E-mail: [email protected]: www.karvy.comToll Free No. of exclusive Call Centre:1-800-345001 Karvy Selenium Tower B, Plot 31-32 Gachibowli,Financial District Nanakramguda PIN: Tel No: 040 - 67162222/18003094001 Fax No: NULL Email: [email protected] Internet: www.kfintech.com

Management

G Venkateswar Reddy, Company Secretary & Compliance Officer

Ravindranath Kancherla, Chairman

Satyanarayana Chava, Executive Director & Chief Executive Officer

V Ravi Kumar, Executive Director & Chief Financial Officer

CV Lakshmana Rao, Executive Director

Krishna Chaitanya Chava, Executive Director

Soumya Chava, Executive Director

Karnam Sekar, Non Executive Independent Director

Ramesh Subrahmanian, Non Executive Independent Director

Sutapa Banerjee, Independent Director

Shekhar Chintamani Mande, Independent Director